Clinical measures identify vitamin D deficiency in dialysis

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 3, 2010, Pages 460-467

  Bhan, Ishir ^a   Burnett Bowie, Sherri Ann M ^a   Ye, Jun ^a   Tonelli, Marcello ^b   Thadhani, Ravi ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; VITAMIN D;

ADULT; AFRICAN AMERICAN; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; COHORT ANALYSIS; DEMOGRAPHY; EUROPEAN AMERICAN; FEMALE; HEMODIALYSIS; HUMAN; HYPOALBUMINEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PARAMETER; PATIENT IDENTIFICATION; RACE DIFFERENCE; SEX DIFFERENCE; UNITED STATES; VITAMIN D DEFICIENCY; WINTER;

AFRICAN AMERICANS; AGED; ALGORITHMS; BIOLOGICAL MARKERS; DECISION TREES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; HYPOALBUMINEMIA; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; NEURAL NETWORKS (COMPUTER); PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RENAL DIALYSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SEASONS; SEX FACTORS; UNITED STATES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 77749301194     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06440909     Document Type: Article

References (51)

1. Chen TC, Chimeh F, Lu Z, Mathieu J, Person KS, Zhang A, Kohn N, Martinello S, Berkowitz R, Holick MF: Factors that influence the cutaneous synthesis and dietary sources of vitamin D. Arch Biochem Biophys 460: 213-217, 2007
2. Ishimura E, Nishizawa Y, Inaba M, Matsumoto N, Emoto M, Kawagishi T, Shoji S, Okuno S, Kim M, Miki T, Morii H: Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int 55: 1019-1027, 1999
3. Foundation NK: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 42: S1-S201, 2003
4. Holick MF: Vitamin D deficiency. N Engl J Med 357: 266-281, 2007
5. Reichel H, Koeffler HP, Norman AW: Synthesis in vitro of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 by interferon-gamma- stimulated normal human bone marrow and alveolar macrophages. J Biol Chem 262: 10931-10937, 1987
6. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, Bals R, Steinmeyer A, Zügel U, Gallo RL, Eisenberg D, Hewison M, Hollis BW, Adams JS, Bloom BR, Modlin RL: Toll-like receptor triggering of a vitamin Dmediated human antimicrobial response. Science 311: 1770-1773, 2006
7. Gombart AF, Bhan I, Borregaard N, Tamez H, Camargo CA Jr, Koeffler HP, Thadhani R: Low plasma level of cathelicidin antimicrobial peptide (hCAP18) predicts increased infectious disease mortality in patients undergoing hemodialysis. Clin Infect Dis 48: 418-424, 2009
8. Wolf M, Shah A, Gutierrez O, Ankers E, Monroy M, Tamez H, Steele D, Chang Y, Camargo CA Jr, Tonelli M, Thadhani R: Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 72: 1004-1013, 2007
9. Ravani P, Malberti F, Tripepi G, Pecchini P, Cutrupi S, Pizzini P, Mallamaci F, Zoccali C: Vitamin D levels and patient outcome in chronic kidney disease. Kidney Int 75: 88-95, 2009
10. London GM, Guérin AP, Verbeke FH, Pannier B, Boutouyrie P, Marchais SJ, Mëtivier F: Mineral metabolism and arterial functions in end-stage renal disease: Potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 18: 613-620, 2007
11. Saab G, Young DO, Gincherman Y, Giles K, Norwood K, Coyne DW: Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients. Nephron Clin Pract 105: c132-138, 2007
12. Blair D, Byhamgray L, Lewis E, Mccaffrey S: Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients. J Ren Nutr 18: 375-382, 2008
13. Holick MF: High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 81: 353-373, 2006
14. Gordon CM, DePeter KC, Feldman HA, Grace E, Emans SJ: Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med 158: 531-537, 2004
15. Benjamin A, Moriakova A, Akhter N, Rao D, Xie H, Kukreja S, Barengolts E: Determinants of 25-hydroxyvitamin D levels in African-American and Caucasian male veterans. Osteoporos Int 20: 1795-1803, 2009
16. Bodnar LM, Catov JM, Wisner KL, Klebanoff MA: Racial and seasonal differences in 25-hydroxyvitamin D detected in maternal sera frozen for over 40 years. Br J Nutr 101: 278-284, 2009
17. Hirani V, Mosdøl A, Mishra G: Predictors of 25-hydroxyvitamin D status among adults in two British national surveys. Br J Nutr 101: 760-764, 2009
18. Jacob AI, Sallman A, Santiz Z, Hollis BW: Defective photoproduction of cholecalciferol in normal and uremic humans. J Nutr 114: 1313-1319, 1984
19. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 289: F8-F28, 2005
20. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R: Estimates of optimal vitamin D status. Osteoporos Int 16: 713-716, 2005
21. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B: Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84: 18-28, 2006
22. Malabanan A, Veronikis IE, Holick MF: Redefining vitamin D insufficiency. Lancet 351: 805-806, 1998
23. Holick MF, Chen TC, Lu Z, Sauter E. Vitamin D and skin physiology: a D-lightful story. J Bone Miner Res 22[Suppl 2]: V28-V33, 2007
24. Holick MF: The use and interpretation of assays for vitamin D and its metabolites. J Nutr 120[Suppl 11]: 1464-1469, 1990
25. Ginde AA, Liu MC, Camargo CA: Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 169: 626-632, 2009
26. LaClair RE, Hellman RN, Karp SL, Kraus M, Ofner S, Li Q, Graves KL, Moe SM: Prevalence of calcidiol deficiency in CKD: A cross-sectional study across latitudes in the United States. Am J Kidney Dis 45: 1026-1033, 2005
27. Grobman WA, Stamilio DM: Methods of clinical prediction. Am J Obstet Gynecol 194: 888-894, 2006
28. Tu JV: Advantages and disadvantages of using artificial neural networks versus logistic regression for predicting medical outcomes. J Clin Epidemiol 49: 1225-1231, 1996
29. Tafeit E, Reibnegger G: Artificial neural networks in laboratory medicine and medical outcome prediction. Clin Chem Lab Med 37: 845-853, 1999
30. Fonarow GC, Adams KF, Abraham WT, Yancy CW, Boscardin WJ: ADHERE Scientific Advisory Committee, Study Group, and Investigators. Risk stratification for inhospital mortality in acutely decompensated heart failure: Classification and regression tree analysis. JAMA 293: 572-580, 2005
31. Goldman L, Cook EF, Brand DA, Lee TH, Rouan GW, Weisberg MC, Acampora D, Stasiulewicz C, Walshon J, Terranova G: A computer protocol to predict myocardial infarction in emergency department patients with chest pain. N Engl J Med 318: 797-803, 1988
32. Lemon SC, Roy J, Clark MA, Friedmann PD, Rakowski W: Classification and regression tree analysis in public health: Methodological review and comparison with logistic regression. Ann Behav Med 26: 172-181, 2003
33. Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, El-Hajj Fuleihan G, Josse RG, Lips P, Morales-Torres J; IOF Committee of Scientific Advisors (CSA) Nutrition Working Group: Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 20: 1807-1820, 2009
34. Bikle DD: Vitamin D insufficiency/deficiency in gastrointestinal disorders. J Bone Miner Res 22[Suppl 2]: V50-V54, 2007
35. Grymonprez A, Proesmans W, Van Dyck M, Jans I, Goos G, Bouillon R: Vitamin D metabolites in childhood nephrotic syndrome. Pediatr Nephrol 9: 278-281, 1995
36. Koenig KG, Lindberg JS, Zerwekh JE, Padalino PK, Cushner HM, Copley JB: Free and total 1,25-dihydroxyvitamin D levels in subjects with renal disease. Kidney Int 41: 161-165, 1992
37. Al-Aly Z, Qazi RA, González EA, Zeringue A, Martin KJ: Changes in serum 25-hydroxyvitamin D and plasma intact PTH levels following treatment with ergocalciferol in patients with CKD. Am J Kidney Dis 50: 59-68, 2007
38. Zisman AL, Hristova M, Ho LT, Sprague SM: Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease. Am J Nephrol 27: 36-43, 2007
39. Buccianti G, Bianchi ML, Valenti G, Lorenz M, Cresseri D: Effects of calcifediol treatment on the progression of renal osteodystrophy during continuous ambulatory peritoneal dialysis. Nephron 56: 353-356, 1990
40. Jean G, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C: Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: Evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment. Nephron Clin Pract 110: c58-c65, 2008
41. Kalantar-Zadeh K, Kuwae N, Regidor DL, Kovesdy CP, Kilpatrick RD, Shinaberger CS, McAllister CJ, Budoff MJ, Salusky IB, Kopple JD: Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 70: 771-780, 2006
42. Kovesdy CP, Ahmadzadeh S, Anderson JE, Kalantar-Zadeh K: Association of activated vitamin D treatment and mortality in chronic kidney disease. Arch Intern Med 168: 397-403, 2008
43. Melamed ML, Eustace JA, Plantinga L, Jaar BG, Fink NE, Coresh J, Klag MJ, Powe NR: Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal study. Kidney Int 70: 351-357, 2006
44. Naves-Díaz M, Alvarez-Hernández D, Passlick-Deetjen J, Guinsburg A, Marelli C, Rodriguez-Puyol D, Cannata-Andía JB: Oral active vitamin D is associated with improved survival in hemodialysis patients. Kidney Int 74: 1070-1078, 2008
45. Shoben A, Rudser K, De Boer I, Young B, Kestenbaum B: Association of oral calcitriol with improved survival in nondialyzed CKD. J Am Soc Nephrol 19: 1613-1619, 2008
46. Teng M, Wolf M, Lowrie E, Ofsthun N, Lazarus JM, Thadhani R: Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 349: 446-456, 2003
47. Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernán MA, Camargo CA Jr, Thadhani R: Activated injectable vitamin D and hemodialysis survival: A historical cohort study. J Am Soc Nephrol 16: 1115-1125, 2005
48. Zehnder D, Bland R, Williams MC, McNinch RW, Howie AJ, Stewart PM, Hewison M: Extrarenal expression of 25-hydroxyvitamin D(3)-1 alpha-hydroxylase. J Clin Endocrinol Metab 86: 888-894, 2001
49. Lee PS, Sampath K, Karumanchi SA, Tamez H, Bhan I, Isakova T, Gutierrez OM, Wolf M, Chang Y, Stossel TP, Thadhani R. Plasma gelsolin and circulating actin correlate with hemodialysis mortality. J Am Soc Nephrol 20: 1140-1148, 2009
50. DIVINE: Dialysis Infection and Vitamin D in New England. Available online at http://www.clinicaltrials. gov/ct2/show/NCT00892099. Accessed January 5, 2010.
51. Cook NR: Statistical evaluation of prognostic versus diagnostic models: Beyond the ROC curve. Clin Chem 54: 17-23, 2008